← All Sponsors
SPONSOR

Benjamin T Diamond, MD

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Refractory Multiple MyelomaRelapsed Multiple Myeloma
NCT05896228 Phase 2
Recruiting

Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma

Refractory Multiple Myeloma
United States View Trial →